Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Children May Experience Gadolinium Retention After Multiple Macrocylic MRI Contrast Dye Exposures

Multiple studies have already confirmed the potential or gadolinium to remain in the body following the administration of Omniscan and other linear MRI contrast dyes. However, new research now suggests that children may also experience gadolinium retention when they undergo … Continue reading

DePuy Reaches Metal-on-Metal Hip Settlement with 46 States

DePuy Orthopeadics has agreed to pay more than $120 million to settle a metal-on-metal hip lawsuit filed by a consortium of 46 state attorneys general. According to Reuters, the settlement resolves allegations that DePuy engaged in unfair and deceptive practices … Continue reading

Another Military Vet Files Lawsuit Over Allegedly Defective 3M Combat Arms Earplugs

A man from Texas has become the latest United States veteran to file a lawsuit over allegedly defective 3M Combat Arms Earplugs. According to a complaint filed in the U.S. District Court, Western District of Texas, on January 22nd, retired … Continue reading

FDA Head Threatens to Ban E-Cigarettes, as Youth Epidemic Shows No Sign of Slowing

The head of the U.S. Food & Drug Administration (FDA) has threatened once again to ban e-cigarettes, warning JUUL Labs and other manufacturers that they face an “existential threat” if they don’t stop marketing their products to children and teens. … Continue reading

FDA Announces Irbesartan Recall, After Cancer-Causing Chemical Turns Up in More Generic ARBs

The U.S. Food & Drug Administration (FDA) has announced another irbesartan recall, after unacceptable amounts of N-Nitrosodiethylamine (NDEA) were detected in the active ingredient used to make the medication. Irbesartan Recall Third Involving Contaminated ARBs this Month According to the … Continue reading

EPA Glyphosate Review Ignored Studies that Echoed IARC Cancer Findings

A recently published analysis is raising new questions about the U.S. Environmental Protection Agency’s (EPA) decision to declare glyphosate safe in 2017. Paper Compares IARC & EPA Glyphosate Reviews Glyphosate is the active ingredient in Monsanto’s Roundup herbicide, the most … Continue reading

Marine Vet Files 3M Combat Arms Earplugs Lawsuit Over Permanent Hearing Loss

A United States Marine Corps veteran has filed a lawsuit for hearing loss allegedly caused by 3M Combat Arms Earplugs. According a complaint filed in U.S. District Court, Central District of California, on January 15th, Andrew Bridges enlisted with the … Continue reading

C.R. Bard Denied Bid to Seal Documents Admitted in IVC Filter Lawsuit Trials

The federal judge overseeing thousands of lawsuits involving C.R. Bard, Inc.’s inferior vena cava (IVC) filters has denied the company’s bid to keep certain documents under seal. According to Reuters, the documents in question were admitted into evidence but only … Continue reading

Uloric Side Effects: FDA Panel Addresses Cardiovascular Risks Associated with Takeda Gout Drug

A panel of outside advisors for the U.S. Food & Drug Administration (FDA) has finished its review of Uloric, concluding that the gout drug’s association with an increased risk of cardiovascular death and serious heart problems outweigh its benefits for … Continue reading

3M Agrees to Pay $9.1 Million for Allegedly Defective Military Earplugs

The 3M Company recently agreed to settle a federal whistleblower lawsuit over allegedly defective military earplugs for $9.1 million. The settlement, which was announced last July by the U.S. Department of Justice, involved 3M Combat Arms Earplugs, Version 2 (CAEv2), … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content